{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:03:38Z","timestamp":1794470618773,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":13,"publisher":"Springer New York","isbn-type":[{"value":"9781493903627","type":"print"},{"value":"9781493903634","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-1-4939-0363-4_9","type":"book-chapter","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T04:27:15Z","timestamp":1393216035000},"page":"147-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Antibody Labeling with Radioiodine and Radiometals"],"prefix":"10.1007","author":[{"given":"Suprit","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,3]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nrd1413","volume":"3","author":"DE Milenic","year":"2004","unstructured":"Milenic DE, Brady ED, Brechbiel MW (2004) Antibody-targeted radiation cancer therapy. Nat Rev Drug Discov 3:488\u2013499","journal-title":"Nat Rev Drug Discov"},{"key":"9_CR2","first-page":"1902","volume":"36","author":"JA O\u2019Donoghue","year":"1995","unstructured":"O\u2019Donoghue JA, Bardies M, Wheldon TE (1995) Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides. J Nucl Med 36:1902\u20131909","journal-title":"J Nucl Med"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF01210552","volume":"29","author":"G Makrigiorgos","year":"1990","unstructured":"Makrigiorgos G, Adelstein SJ, Kassis AI (1990) Auger electron emitters: insights gained from in vitro experiments. Radiat Environ Biophys 29:75\u201391","journal-title":"Radiat Environ Biophys"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00259-004-1664-0","volume":"32","author":"SC Chauhan","year":"2005","unstructured":"Chauhan SC, Jain M, Moore ED, Wittel UA, Li J, Gwilt PR, Colcher D, Batra SK (2005) Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49. Eur J Nucl Med Mol Imaging 32:264\u2013273","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0958-1669(02)00352-X","volume":"13","author":"SK Batra","year":"2002","unstructured":"Batra SK, Jain M, Wittel UA, Chauhan SC, Colcher D (2002) Pharmacokinetics and biodistribution of genetically engineered antibodies. Curr Opin Biotechnol 13:603\u2013608","journal-title":"Curr Opin Biotechnol"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.tibtech.2007.05.001","volume":"25","author":"M Jain","year":"2007","unstructured":"Jain M, Kamal N, Batra SK (2007) Engineering antibodies for clinical applications. Trends Biotechnol 25:307\u2013316","journal-title":"Trends Biotechnol"},{"key":"9_CR7","first-page":"149","volume":"3","author":"WT Anderson","year":"1987","unstructured":"Anderson WT, Strand M (1987) Radiolabeled antibody: iodine versus radiometal chelates. NCI Monogr 3:149\u2013151","journal-title":"NCI Monogr"},{"key":"9_CR8","first-page":"736","volume":"43","author":"D Colcher","year":"1983","unstructured":"Colcher D, Zalutsky M, Kaplan W, Kufe D, Austin F, Schlom J (1983) Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody. Cancer Res 43:736\u2013742","journal-title":"Cancer Res"},{"key":"9_CR9","first-page":"2022","volume":"31","author":"MJ Abrams","year":"1990","unstructured":"Abrams MJ, Juweid M, TenKate CI, Schwartz DA, Hauser MM, Gaul FE, Fuccello AJ, Rubin RH, Strauss HW, Fischman AJ (1990) Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 31:2022\u20132028","journal-title":"J Nucl Med"},{"key":"9_CR10","first-page":"1519","volume":"42","author":"A Goel","year":"2001","unstructured":"Goel A, Baranowska-Kortylewicz J, Hinrichs SH, Wisecarver J, Pavlinkova G, Augustine S, Colcher D, Booth BJ, Batra SK (2001) 99mTc-labeled divalent and tetravalent CC49 single-chain Fv\u2019s: novel imaging agents for rapid in vivo localization of human colon carcinoma. J Nucl Med 42:1519\u20131527","journal-title":"J Nucl Med"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680\u2013685","journal-title":"Nature"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.nucmedbio.2008.11.001","volume":"36","author":"M Hens","year":"2009","unstructured":"Hens M, Vaidyanathan G, Welsh P, Zalutsky MR (2009) Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with (177)Lu: in vitro comparison of acyclic and macrocyclic ligands. Nucl Med Biol 36:117\u2013128","journal-title":"Nucl Med Biol"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.nucmedbio.2010.04.020","volume":"37","author":"M Hens","year":"2010","unstructured":"Hens M, Vaidyanathan G, Zhao XG, Bigner DD, Zalutsky MR (2010) Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands. Nucl Med Biol 37:741\u2013750","journal-title":"Nucl Med Biol"}],"container-title":["Methods in Molecular Biology","Drug Delivery System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-0363-4_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T19:29:53Z","timestamp":1676834993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-0363-4_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9781493903627","9781493903634"],"references-count":13,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-0363-4_9","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-0363-4","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"3 February 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}